Meet Dr. Tara Power
Originally from Truro, Dr. Tara moves back to her hometown from Alberta in 2010 to raise her family and pursue clinical practice. She is a former lawyer (Osgoode Hall Law School) and National Cancer Institute of Canada Post-Doctoral Fellow in Psychosocial Oncology.
Dr. Tara Power’s background includes professional roles, numerous research publications and a significant breadth and depth of clinical experience. Her work specializes in assessment and therapy with adults dealing with stress and anxiety disorders, mood and depression issues, trauma, health behaviors (smoking, food/eating issues, substance misuse, exercise), coping with cancer and chronic illness, life transition issues and sports performance.
As a Ph.D. level psychologist, Dr. Tara has been extensively trained in general mental health as well as the specialized areas of health and sports psychology. Her clinical health psychology experience includes work with patients diagnosed with cancer, chronic disease, spinal cord and brain injury, chronic pain, fertility issues, treatment decision making, and sleep disorders. With respect to disease prevention, she has worked with smoking cessation, food/eating issues, and weight-loss.
In recent years, Dr. Tara has provided service to the Nova Scotia Rehabilitation Centre inpatient units, the CDHA-associated Partners For Healthier Weight Program and the Colchester East Hants Health Authority Persistent Pain Treatment Program. She has provided neuropsychological assessment services to various private and public organizations throughout Nova Scotia and has acted as an expert witness for the courts. Her most recent speaking engagements have related to Life Transitions and Retirement, Relaxation and the Role of Arousal in Sports Performance and Thriving after Cancer Treatment.
With the client’s permission, Dr. Tara also has a therapy trained dog that often accompanies her in session. “Roxanne” is a support trained therapy dog and a member of the therapy team at EmPOWERment Health. With a client’s permission, she is present for most therapy sessions and often assists Dr. Tara in relaxation and mindfulness work. As a poodle mix, she is non-shedding and as hypoallergenic as is possible in a canine.
Power, T.E., Swartzman, L.C., & Robinson, J.W (2011). Cognitive-emotional decision making (CEDM): A framework of patient medical decision making. Patient Education and Counseling 83(2) 163-169.
Power, T.E., Robinson, J.W., Bridge, P., Bernier, F.P. & Gilchrist, D.M. (2011). Distress and Psychosocial Needs of a Heterogeneous High-Risk Familial Cancer Population. Journal of Genetic Counseling 20(3) 249-269
Hall, M.A., Barton, J.C., Adams, P.C., McLaren, C.E., Reiss, J.C., Castro, O., Ruggiero, A., Acton, R.T., Power, T.E. (2007). Genetic screening for iron overload: No evidence of discrimination at one year. Journal of Family Practice 56(10) 829-834
Power, T.E., Adams, P. C., Barton, J.C., Acton, R.A, Howe, E., Palla, S., Walker, A. P., Anderson, R, Harrison, B., Thomson, E. (2007). Psychosocial Impact of Genetic testing for Hemochromatosis in the HEIRS Study: A comparison of participants recruited in Canada and in the United States. Genetic Testing 11(1), 55-64
Power, T.E. & Robinson, J (2006).Genetic mutation-related cancers: Important psychosocial issues for the Canadian general medical practitioner. Canadian Family Physician 52(11), 1425-1431
Anderson, R., Wenzel, L., Walker, A.P., Ruggiero, A., Acton, R., Hall, M.A., Tucker, D., Thompson, E., Harrison, B., Howe III, E., Holup, J., Leiendecker-Foster, C., Power, T.E., Adams, P.C. (2006). Impact of Hemochromatosis Screening In Patients with Indeterminate Results: The HEIRS Study. Genetics In Medicine 8(11), 681-687
Power, T.E. & Robinson, J.W. (2006). Addressing the psychosocial, ethical and legal issues of genetic mutation –related cancers. Oncology Exchange 5, 18-29
Hall, M.A., McEwen, J.E., Barton, J.C., Walker, A.P., Howe, E.G., Reiss, J.A. Power, T.E., Ellis, S.D., Tucker, D.C., Harrison, B.W., McLaren, G.D., Ruggiero, A. and Thomson,, E.J. (2005). Concerns in the primary care population about genetic discrimination by insurers. Genetics in Medicine 7(5), 311-316.
Power. T.E. (2005). Supporting a friend with a BRCA1/2 mutation. A response to am HBOC member. Gene Scene, Hereditary Breast, and Ovarian Cancer Newsletter, December 2005.
Power. T.E. & Adams, P.C. (2004). Hemochromatosis patients as voluntary blood donors. Canadian Journal of Gastroenterology 18(6), 393-396
Power, T.E. & Swartzman, L.C. (2003). Emotional and Cognitive factors in the decision to undertake BRCA1/2 testing in a community sample of Jewish women of Ashkenazi descent. Medical Decision Making 23(7).
Power, T. E. & Adams, P.C. (2001). The Psychosocial impact of C282Y mutation testing for hemochromatosis. Journal of Genetic Testing 5(2), 107-111.